Novartis keeps CEO pay steady, but incoming chairman pay drops
BASEL (Reuters) - Novartis kept pay for its Chief Executive Joe Jimenez steady, after cutting it last year before a Swiss vote to force companies to accept shareholder limits on executive rewards.
Related Articles
- Germany's Corporate Governance Problem also categorized in BoardNews
- CEOs and Executives of Companies Filing for Bankruptcy Make Millions also categorized in BoardNews
- Why Illinois Shouldn't Mandate Quotas for Company Boards also published in Chicago Tribune
- Lululemon Strips Its Billionaire Founder Chip Wilson Of Board Appointment also categorized in BoardNews
- Breaking News: Standley Is Out As Rite Aid CEO In Shakeup also categorized in BoardNews
- Lululemon Has A New CEO also written by Reuters
- Coca-Cola Faces Renewed Pressure Over Executive Pay also written by Reuters
- TaskRabbit CEO Steps Down, Making Silicon Valley’s Diversity Outlook Bleak also categorized in BoardNews
- Two Shareholders Sue American Apparel Over CEO's Ouster also written by Reuters
- UBS Still Needs to Get Rid of Investment Bank - Activist Investor also written by Reuters
Login to comment.